Comprehensive Hemato-Oncology Services: Blood Cancer in Amritsar

Comprehensive Hemato-Oncology Services: Blood Cancer in Amritsar

Dr. Amritjot Singh Randhawa

17 Nov 2025

Call +91 80788 80788 to request an appointment.

Targeted therapy & personalized cancer care in Amritsar

At Livasa Hospitals, Livasa Amritsar offers modern, evidence-based precision oncology that combines genetic testing, molecular tumor profiling and personalized treatment plans to improve outcomes for people living with cancer. This article explains what targeted therapy and personalized cancer care mean, who benefits, how genetic testing and next-generation sequencing (NGS) are used in practice, how targeted treatments compare with conventional therapies, costs in Amritsar and Punjab, and what to expect when you seek care at Livasa Amritsar. If you are looking for "targeted therapy Amritsar" or "personalized cancer care Amritsar," this guide aims to help you understand options and next steps.


Introduction

Cancer treatment has evolved from one-size-fits-all chemotherapy and radiation to approaches that address the specific biology of each patient’s tumor. Targeted therapy and precision oncology use molecular information from a person’s cancer—such as mutations, gene expression patterns and biomarkers—to select drugs that are more likely to work and less likely to cause unnecessary side effects. In Amritsar and across Punjab, access to targeted cancer therapy and genetic testing for cancer is growing rapidly as hospitals adopt molecular testing platforms like next generation sequencing (NGS) and immunohistochemistry panels.

Globally, according to GLOBOCAN 2020, there were an estimated 19.3 million new cancer cases and about 10 million cancer deaths in 2020. India accounted for over one million new cases in 2020, and a growing proportion of those patients are being evaluated for molecularly guided treatments. In local practice, major centers in Punjab—including referral centers in Amritsar—now offer molecular tumor profiling Amritsar services and mutation analysis to match patients with the most effective targeted agents or clinical trials.

This article is intended for patients, caregivers and families seeking reliable, patient-friendly information about targeted therapies, precision medicine oncology specialists, and where to get molecular testing and personalized cancer treatment near me in Amritsar.


What is targeted therapy and precision oncology?

Targeted therapy refers to drugs or substances that interfere with specific molecules or signalling pathways involved in cancer growth and progression. Unlike traditional chemotherapy, which broadly attacks dividing cells, targeted agents are designed to block processes essential to the cancer cell while sparing normal tissue. Examples include tyrosine kinase inhibitors that block growth signals and monoclonal antibodies that target cell-surface receptors.

Precision oncology is the broader clinical approach that uses genetic, genomic and molecular information about the tumor (and sometimes the patient’s inherited genetic profile) to guide prevention, screening, diagnosis and treatment. Precision oncology integrates technologies such as:

  • Next generation sequencing (NGS) for multi-gene panels and whole-exome profiling.
  • Molecular tumor profiling to identify actionable mutations, fusions and copy number changes.
  • Immunohistochemistry (IHC) and fluorescence in situ hybridization (FISH) for protein or gene rearrangement tests.
  • Liquid biopsy (circulating tumor DNA) for non-invasive mutation testing and monitoring.

When a patient’s cancer harbors a known actionable alteration—such as EGFR mutations in lung cancer, HER2 amplification in breast cancer, BRAF V600E in melanoma and colorectal cancer, or ALK and ROS1 fusions—targeted therapy can provide dramatic clinical benefit, including tumor shrinkage, symptom relief and prolonged survival. Precision oncology also includes the use of biomarkers to predict response to immunotherapy (for example, PD-L1 expression or tumor mutational burden).

In Amritsar and the wider Punjab region, targeted therapy Amritsar services increasingly use multidisciplinary tumor boards that include medical oncologists, radiation oncologists, pathologists, medical geneticists and molecular biologists to interpret molecular test results and recommend the best personalized treatment path.


How personalized cancer care works: from biopsy to treatment

Personalized cancer care starts with obtaining and analyzing tissue or blood samples to determine the tumor’s molecular profile. The typical workflow includes several steps:

  • Clinical evaluation: Detailed history, imaging and pathology review to determine stage and possible molecular tests.
  • Sample collection: Core biopsy, surgical specimen or blood draw for liquid biopsy.
  • Molecular testing: Depending on the case, single-gene tests, multi-gene NGS panels, IHC, FISH or PCR assays are performed to identify actionable mutations, gene fusions, amplifications and biomarkers.
  • Interpretation: Molecular pathologists and molecular tumor boards interpret test results and recommend targeted agents, immunotherapy, or clinical trials.
  • Treatment selection: Based on molecular findings, clinicians choose an approved targeted drug, combine targeted therapy with other modalities, or enroll the patient in a precision medicine trial.
  • Monitoring: Response is monitored clinically and radiologically; liquid biopsy may be used to detect emerging resistance mutations that guide subsequent therapy.

Technologies such as NGS allow simultaneous testing of dozens to hundreds of genes; this increases the chance of identifying an actionable change, particularly in advanced cancers. In Amritsar, genetic testing cancer Amritsar and molecular testing for cancer Amritsar are available at major oncology centers including Livasa Amritsar, with standardized sample handling and reporting to international quality standards.

A key advantage of precision oncology is that it helps avoid ineffective treatments. For example, if a tumor lacks the biomarker for a specific drug, the patient can be spared the cost and toxicity of that agent and offered an alternative therapy more likely to help.


Who benefits from targeted therapy: cancer types and indications

Targeted therapy benefits patients whose tumors have specific molecular alterations or biomarkers predictive of response. The list of cancers with established targeted options continues to grow. Common examples include:

  • Lung cancer (non-small cell): EGFR mutations, ALK/ROS1/RET fusions and MET exon 14 skipping events guide use of targeted tyrosine kinase inhibitors (TKIs).
  • Breast cancer: HER2 amplification (trastuzumab and other anti-HER2 agents), PIK3CA mutations (alpelisib) and BRCA mutations (PARP inhibitors) in selected settings.
  • Colorectal cancer: RAS wild-type tumors may benefit from anti-EGFR antibodies; BRAF V600E and MSI-high status inform different targeted and immunotherapy strategies.
  • Melanoma: BRAF V600E/K mutations respond to BRAF and MEK inhibitor combinations.
  • Hematologic cancers: Multiple targeted agents exist for chronic myeloid leukemia (BCR-ABL inhibitors), FLT3-mutated AML, and other leukemias and lymphomas.
  • Rare cancers and sarcomas: Gene fusions and niche targets that can be exploited if identified by broad NGS testing.

Not every patient with a particular cancer will be eligible for a targeted drug; the tumor must have the actionable alteration, and other clinical factors such as performance status, prior therapies and comorbidities are considered. In Amritsar, multidisciplinary tumor boards at Livasa Amritsar review complex cases and can recommend targeted therapy, referral to higher-level centers, or enrollment onto research protocols where appropriate.

For patients and families in Punjab, asking your oncologist about tumour mutation testing Amritsar or biomarker testing for cancer Amritsar is a practical way to determine whether precision therapy could be beneficial.


Genetic testing, mutation analysis and NGS: options available in Amritsar

Genetic testing in cancer can mean two distinct things: testing the tumor (somatic testing) to identify mutations that drive the cancer, and testing the patient’s inherited DNA (germline testing) to detect hereditary cancer predisposition. Both are important but serve different purposes.

Common testing options available at Livasa Amritsar and other precision oncology centers include:

  • Single-gene testing: Used when a specific mutation is strongly suspected (e.g., EGFR test in lung adenocarcinoma).
  • Multi-gene NGS panels: Panels that test 20–500 genes simultaneously to identify actionable targets and resistance mechanisms.
  • Whole-exome or whole-genome sequencing: Research-focused; used selectively when standard testing is uninformative.
  • Liquid biopsy (ctDNA): Non-invasive blood tests useful for mutation detection when tumor tissue is limited or for monitoring resistance.
  • Germline genetic testing: For hereditary syndromes (BRCA1/2, Lynch syndrome genes, etc.) to guide prevention and family counseling.

When considering "where to get genetic testing for cancer in Amritsar," Livasa Amritsar provides molecular testing coordination, sample collection and access to accredited partner laboratories for advanced NGS panels and tumor profiling. Reports are discussed by multidisciplinary teams, and medical genetics Amritsar support and genetic counseling are provided when germline mutations are discovered.

For clinicians and patients in Punjab, common questions include the turnaround time for NGS (typically 7–21 days depending on the test), the sensitivity of liquid biopsy versus tissue tests, and when to repeat testing at progression. Livasa’s precision oncology team helps navigate these choices and explains results in patient-friendly language.


Comparing treatment approaches: targeted therapy, chemotherapy and immunotherapy

Choosing the right therapy depends on tumor type, stage, molecular profile and patient factors. The table below summarizes key differences among targeted therapy, chemotherapy and immunotherapy to help patients and families understand trade-offs and benefits.

Treatment type When used Benefits Limitations
Targeted therapy Tumors with actionable mutations/biomarkers (EGFR, HER2, BRAF, etc.) Higher response rates when target present; often oral agents; fewer off-target toxicities Not effective without the target; resistance can develop; cost can be high
Chemotherapy Broadly used for many cancers and stages Well-established, affordable options; effective for many cancers Non-specific toxicity (hair loss, nausea, low blood counts); may be less effective for target-driven tumors
Immunotherapy Tumors with high PD-L1, MSI-high, high tumor mutational burden or certain cancer types Durable responses in some patients; can produce long-term remission Only a subset respond; immune-related adverse events can be serious; high cost

In many cases, combinations are used—for example, targeted agents with chemotherapy or targeted therapy followed by immunotherapy. Personalized recommendations are based on molecular test results and patient preferences. Livasa Amritsar’s oncology teams provide clear explanations of expected benefits and potential side effects to help families make informed decisions.


Side effects of targeted therapy and their management

While targeted therapies are often better tolerated than conventional chemotherapy, they are not free of side effects. Because they act on specific molecular pathways, adverse events often relate to the normal functions of those pathways in healthy tissues. Common side effects and management strategies include:

  • Skin reactions: Rash and dry skin are common with EGFR inhibitors. Management includes dermatology referral, topical emollients, topical steroids and dose adjustments when necessary.
  • Diarrhea and gastrointestinal symptoms: Seen with many TKIs; treated with hydration, anti-diarrheal medications and dose modification.
  • Fatigue: A frequent complaint; managed with activity pacing, nutrition support and treating underlying causes such as anemia.
  • Cardiac effects: Some targeted drugs (e.g., HER2 therapies, certain kinase inhibitors) can affect heart function, so baseline and periodic cardiac monitoring is important.
  • Hypertension: VEGF pathway inhibitors commonly cause raised blood pressure; antihypertensive therapy and monitoring are used.
  • Hepatic or renal dysfunction: Frequent laboratory monitoring helps detect organ toxicity early and permits dose adjustments.

Effective side-effect management requires communication between the patient and the oncology team. In Amritsar, Livasa Hospitals’ oncology nurses and pharmacists teach patients how to recognize early toxicity signs, use supportive medications properly and when to seek urgent care. Managing side effects well helps patients stay on therapy and maintain quality of life.

If you are searching for "targeted therapy side effects and management Amritsar" or need urgent advice, contact Livasa Amritsar at +91 80788 80788. The team provides phone guidance and urgent clinic appointments when needed.


Costs and access: targeted therapy and genetic testing in Amritsar and Punjab

Cost considerations are important when evaluating targeted therapies and molecular testing. Prices vary depending on the test complexity, the drug chosen and whether the medication is branded, generic or available through patient-access programs. Below is a general comparison of testing and treatment cost ranges commonly seen in Amritsar and across Punjab. These figures are approximate and intended for planning discussion:

Service Typical cost range (INR) Notes
Single-gene test (e.g., EGFR) ₹5,000 – ₹18,000 Quick and less expensive when a specific mutation is suspected
Multi-gene NGS panel (50–500 genes) ₹25,000 – ₹90,000 Higher diagnostic yield; often recommended for advanced cancers
Liquid biopsy (ctDNA) ₹20,000 – ₹60,000 Useful for monitoring and when tissue is unavailable
Targeted therapy (monthly) ₹20,000 – ₹300,000+ Wide range depending on drug, dose and whether generic is available
Immunotherapy (per dose) ₹1,00,000 – ₹3,50,000 Often administered every 2–3 weeks; programs and insurance may help

Many patients benefit from financial counseling, patient assistance programs from drug manufacturers, insurance claims support and government schemes. At Livasa Amritsar, the patient support team helps identify subsidies, special rates and compassionate-use programs when possible. If cost is a concern, ask your oncologist about prioritizing the most informative tests (for example, focused NGS panels) and exploring access pathways for essential targeted medicines.

For current and personalized cost estimates—such as "targeted cancer therapy cost in Amritsar" or "cost of targeted therapy Amritsar"—call Livasa Amritsar at +91 80788 80788 or request an appointment online at Book an appointment.


Choosing the right center and specialists in Amritsar: why Livasa Amritsar

When you search for "best precision oncology center Amritsar" or "top oncologist for targeted therapy Amritsar," consider several factors:

  • Multidisciplinary care: A coordinated team including medical oncologists, surgical oncologists, radiation oncologists, molecular pathologists and genetic counselors.
  • On-site molecular diagnostics: Availability of NGS, IHC, FISH and liquid biopsy or established partnerships with accredited labs for rapid turnaround.
  • Clinical trial access: Options to enroll in trials when standard therapies are limited.
  • Support services: Nursing, pharmacy, nutrition, psychosocial support and rehabilitation for holistic care.
  • Transparent communication: Clear reporting of test results and shared decision-making for treatment planning.

Livasa Amritsar offers precision oncology services that align with these criteria. Patients receive individualized treatment plans based on molecular tumor profiling, access to NGS and mutation analysis Amritsar services, and support through the treatment journey. The oncology team holds regular tumor board meetings to review complex cases and ensure that molecular test results translate into meaningful therapeutic choices.

If you are considering second opinions, seeking targeted therapy for breast cancer in Amritsar, targeted therapy for lung cancer Amritsar, or general precision medicine oncology specialists Amritsar, Livasa Amritsar provides consultations tailored to your diagnosis and goals. To schedule a targeted therapy consultation Amritsar at Livasa, call +91 80788 80788 or use the appointment link: https://www.livasahospitals.com/appointment.


Frequently asked questions and next steps

Patients frequently ask practical questions when considering precision oncology. Below are clear answers to common queries:

  • Do I need genetic testing for every cancer? Not always. Testing is recommended when the result will change treatment decisions—for example, in advanced lung, breast, colorectal or melanoma, or when hereditary risk is suspected.
  • What is the difference between tumor testing and germline testing? Tumor (somatic) testing finds mutations in the cancer cells that guide targeted treatments. Germline testing looks for inherited mutations that affect cancer risk for you and your family.
  • How long does NGS take? Most panels have a turnaround of 1–3 weeks, depending on sample quality and lab logistics.
  • Will insurance cover targeted therapy or testing? Coverage varies. Livasa Amritsar’s financial counselors can help you explore insurance approvals, government schemes and assistance programs from pharmaceutical companies.
  • Can I get targeted therapy near me in Amritsar? Yes. Livasa Amritsar provides targeted therapy and precision oncology services locally, with access to molecular testing, multidisciplinary care and supportive services.

Next steps if you or a loved one are exploring targeted therapy and personalized cancer care in Amritsar:

  1. Collect previous pathology reports and imaging studies.
  2. Request a consultation with a medical oncologist experienced in precision oncology.
  3. Discuss molecular testing options and affordability; choose tissue or liquid biopsy as advised.
  4. Attend the molecular tumor board review and receive a personalized treatment plan.
  5. Engage support services—nutrition, symptom management and psychosocial care—throughout treatment.

Contact Livasa Amritsar

For expert guidance on targeted therapy, molecular testing and personalized cancer treatment in Amritsar and Punjab, contact Livasa Hospitals — Livasa Amritsar. Our precision oncology team is available to evaluate your case, coordinate genetic testing and design an individualized treatment plan.

Phone: +91 80788 80788

Online booking: https://www.livasahospitals.com/appointment

Whether you are searching for "precision oncology services Livasa Amritsar", "mutation analysis Amritsar", or "where to get genetic testing for cancer in Amritsar", our team is ready to help. Early evaluation and appropriate molecular testing can open treatment opportunities that improve outcomes and quality of life.

Disclaimer: This article provides general information about targeted therapy and precision oncology. Specific medical decisions should be made in consultation with your treating oncologist. Cost ranges and turnaround times are approximate and may vary.

Request an Appointment

Need Help?

Call US

+91 80788 80788

Address

Livasa Healthcare Group Corporate Office,Phase-8, Industrial Area, Sector 73, Sahibzada Ajit Singh Nagar, Punjab 160071

Email

livasacare@livasahospitals.in